Abstract Submission

Abstract Submission Guidelines:

Please read the following guidelines carefully before submitting your abstract:

  • Abstracts for the MWIA conference must be submitted in English, French and Arabic.
  • Abstracts can ONLY be submitted online via the conference website at www.kmwa.or.ke/mwia-near-east-and-africa-regional-meeting/
  • All submissions receive an acknowledgement upon successful submission via the website with
  • The abstract text should not exceed 350 words.
  • The number of authors per abstract is unlimited. However, only one author can be listed as the presenting author.
  • Please use a standard font like Calibri or Arial when formatting the text. This will help to prevent special characters from getting lost when copying text to the online abstract submission form.
  • Please note that- Tables, figures, literature references, and acknowledgments should not form any part of the abstract’s content
  • It is the author’s responsibility to submit a correct abstract. Any errors in spelling, grammar or scientific fact will be reproduced as typed by the author.
  • Abstracts must not have been published for presentation to any other national or international meeting. However, an abstract that was submitted but was not accepted in previous conferences is valid and may be submitted for MWIA Regional Conference for Near East and Africa 2018.
  • Please define all abbreviations and concepts in your abstract at the first use.
  • For therapeutic agents, only generic names may be used (trade names are not permitted).
  • If you have any questions regarding your abstract submission, please contact the abstract support team at e-mail address: conference@kmwa.or.ke

The Conference offers two options for abstract submission: OPTION 1 and OPTION 2.

OPTION 1:

The first option is most suited for scientific research. Abstracts presented under the first option should contain concise statements of:

  • Title: Each Abstract should have a title for the paper or poster
  • Introduction/Background: Explains in brief the genesis of the research, the hypothesis that was tested or a description of the problem being analyzed or evaluated.
  • Objectives: Indicate the purpose and reasons for the research study.
  • Methodology: Describe the setting/location for the study, the research design, study population, data collection and methods of analysis used.
  • Results: Presents the study findings/outcome with specific results in summarized form.
  • Innovation: Indicates new thinking or advancements in an idea, process, or otherwise based on the study
  • Appropriateness:  Indicates the relevance of the research in relation to the theme or given tracks
  • Conclusions and Recommendations: Briefly discusses the data and main outcome of the study and the next steps or suggestions.

OPTION 2:

The second option is most suited for presenting policy, case studies and life stories type of papers. These would also include testimonials, inventions and innovations. This option is suited for information that was gained through systematic forms of knowledge production and/or management, by means other than scientific research or evaluation including community level experiences and best practices in the various topical areas outlined in the conference tracks.

Abstracts presented under the second option should contain concise statements of:

  • Title: Each Abstract should have a title
  • Background/ Problem Statement/ Issues: Explains in brief the genesis of the research, the hypothesis that was tested or a description of the problem being analyzed or evaluated or policy gap .
  • Description: a description of the intervention, project, experience, service and/or advocacy.
  • Suggestions for Policy Guidelines/ or lessons learned: These would include conclusions and implications of the intervention or project. Data that support the lessons learned and evidence should be included.
  • Conclusions and Recommendations/Next steps: possible next steps for implementation, or recommendations

 

Abstracts should disclose primary findings and avoid, whenever possible, promissory statements such as “experiments are in progress” or “results will be discussed”.

 

The abstract submitted, if accepted, will appear in its full form in the abstract book, and/or on the abstract CD-ROM and on the KMWA conference website.

Abstract Transparency Policy

An abstract can be submitted and may be accepted although it has been previously published or presented at a national, regional or international meeting, provided that there are new methods, new findings, updated information or other valid reasons for submitting that can be provided by the author.

If preliminary or partial data has been published or presented, the author is required to indicate the details of that conference, meeting or journal and the reasons for submitting the abstract to this conference. The Scientific Program Committee when making the final decisions will consider this information.

Abstract Blind Peer Review

All submitted abstracts will go through a blind peer-review process carried out by a reviewing committee. Two reviewers will review each abstract and an additional review will be carried out at an experts sitting as convened by the scientific committee.

Notification of Acceptance or Rejection to Corresponding Author

Notification of acceptance or rejection will be sent to the submitting (corresponding) author. Please note that only the corresponding author will receive email concerning the abstract and is responsible for informing all others.